AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2023
May 9, 2023
30339_dirs_2023-05-09_68b9225b-2fd0-4cc2-9cd5-98ad1c579b14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-05-05
Reporting Person: Winters Chad (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-05 | Common Stock | F | 10.00 | $368.46 | Disposed | 1448.711 | Direct |
Footnotes
F1: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27